Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, explains the evolution of HIV PrEP from daily oral medications to long-acting injectables and how health policy and payer strategies can improve access, adherence and outcomes.
In this interview, Luis Ortiz, M.D., explains the current and emerging therapies for narcolepsy type 1 treatment.
Evernorth’s Nicole A. Caffiero said specialty drugs dominate the pipeline, FDA approvals and the expenditures on pharmaceuticals during a keynote presentation at the AMCP annual meeting.
A CVS Caremark formulary change in May 2025 led to a short increase in patients switching GLP-1 drugs before prescribing trends leveled off, according to Truveta data presented at AMCP.
In this interview, Luis Ortiz, M.D., explains how burdensome a narcolepsy diagnosis can be for a patient and why listening to their experiences helps shape new guidelines and treatments.
Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, explains how managed care organizations can support patients at risk of HIV.
The Maximum Fair Price (MFP), established by the Inflation Reduction Act, and the Most Favored Nation policy are reshaping how drugs are priced, paid for, and accessed.
Brian MacDonald, Pharm.D., of Prime Therapeutics discusses the low utilization of the gene therapies for hemophilia. Pfizer and BioMarin have pulled their FDA-approved hemophilia gene therapies from the market, citing low demand.
Pfizer and BioMarin have pulled their hemophilia gene therapies, citing low demand.
As CAR-T therapy expands into earlier stages of treatment and new care settings, payers are weighing access, cost savings and utilization management strategies.
Data from an automated refill reminder program identified key patient behaviors and characteristics that strongly predict medication nonadherence, which could enable more targeted interventions by health plans in the future.
From 2023 to 2024, the number of uninsured people in the United States rose for the first time since 2019, mainly because pandemic-era Medicaid protections ended, eligibility checks resumed and many people could not afford or access alternative coverage, according to a new issue brief from KFF.
The anti-obesity market is now the fourth largest and is expected to grow. The pipeline contains 190 obesity-related products, IQVIA’s Scott Biggs said.
How old a person appears may offer insight into how long they live after treatment for early-stage lung cancer.
In this interview, Luis Ortiz, M.D., explains how narcolepsy type 1 is now diagnosed and how it differs from type 2.
Navitus Health Solutions saw both overall savings and reduced patient costs from the switch to the adalimumab biosimilars. Vanderbilt Health, however, experienced increased adverse events after the biosimilar conversation and further switching to other biosimilars or therapies.
Evaluating the costs and outcomes of alternative funding programs requires balancing financial objectives with patient considerations.
At the AMCP Annual Meeting, experts from Prime Therapeutics said education, policy alignment and collaboration can help improve access to precision testing while managing costs.
A large study of more than 780,000 adolescents found that atopic dermatitis is not associated with lower academic performance on national exams in Denmark or England.
Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, explains where managed healthcare organizations should look if they want to improve PrEP access and align with public health goals.
In this video interview, Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, provides an overview of the HIV preventative medicine landscape.
In this first part of a video interview series, Abby Kim, Pharm.D., of Prime Therapeutics shows how advances such as precision medicine and CAR T therapy are improving outcomes while requiring managed care leaders to rethink value through a long-term lens of cost, toxicity and patient access.
A talk by presidential historian Jon Meacham kicked off the official beginning of the meeting at the Music City Center in Nashville, Tennessee.
A multinational study found that metformin use was associated with significantly lower odds of esophageal squamous cell carcinoma, supporting further research into its potential role in cancer prevention and treatment.
A single-arm Japanese trial found that pazopanib did not improve progression-free survival but demonstrated encouraging response rates and overall survival in patients previously treated with paclitaxel.
A study in Translational Psychiatry found that adding rTMS to standard care may quickly improve flu-related sleep issues by targeting brain activity and immune responses linked to insomnia.
Adults in rural Appalachian Kentucky are facing a severe sleep crisis when compared to the rest of the country, a trend exacerbated by income inequality
The 2026 MHE Pharmacy Survey asked questions about most-favored nation drug pricing, PBM reform and HHS Secretary Robert F. Kennedy Jr.'s vaccine policies. Respondents rated direct-to-consumer drug sales by drugmaker as the most important development in the pharmaceutical sector this year.
